Fibroscan Study in HCC

NAActive, not recruitingINTERVENTIONAL
Enrollment

207

Participants

Timeline

Start Date

February 27, 2013

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Confirmed Diagnosis of Hepatocellular CarcinomaPatients Who Are Scheduled to Undergo Transarterial Chemobolization, Systemic Therapy SurgeryChild's A to C Cirrhosis
Interventions
OTHER

Fibroscan

Trial Locations (1)

Unknown

Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT01796145 - Fibroscan Study in HCC | Biotech Hunter | Biotech Hunter